CCM
PRVL

CAAS Capital Management’s Prevail Therapeutics Inc. Common Stock PRVL Stock Holding History

CAAS Capital Management’s Portfolio PRVL Stock Details PRVL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-17,200
Closed -$175K – 700
2020
Q3 		$175K Buy
+17,200
New +$175K ﹤0.01% 251